Patinha, D., Fasching, A., Pinho, D., Albino-Teixeira, A., et al. (2013). Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. American Journal of Physiology - Renal Physiology, 304(5), F614 - F622.

Marques-Lopes, J., Martins, I., Pinho, D., Morato, M., et al. (2012). Decrease in the expression of N-methyl-D-aspartate receptors in the nucleus tractus solitarii induces antinociception and increases blood pressure. Journal of Neuroscience Research, 90(2), 356 - 366.

Sousa, T., Oliveira, S., Afonso, J., Morato, M., et al. (2012). Role of H2O2 in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II. British Journal of Pharmacology, 166(8), 2386 - 2401.

Guimarães, H., Guedes, M. B., Rocha, G., Tomé, T., & Albino-Teixeira, A. (2012). Vitamin A in prevention of bronchopulmonary dysplasia. Current Pharmaceutical Design, 18(21), 3101 - 3113.

Pinho, D., Morato, M., Couto, M. R., Marques-Lopes, J., et al. (2011). Does chronic pain alter the normal interaction between cardiovascular and pain regulatory systems? Pain modulation in the hypertensive-monoarthritic rat. Journal of Pain, 12(2), 194 - 204.

Marques-Lopes, J., Pinho, D., Albino-Teixeira, A., & Tavares, I. (2010). The hyperalgesic effects induced by the injection of angiotensin II into the caudal ventrolateral medulla are mediated by the pontine A5 noradrenergic cell group. Brain Research, 1325, 41 - 52.

Almeida, L., Vaz-Da-Silva, M., Coelho, R., Albino-Teixeira, A., & Soares-Da-Silva, P. (2009). Interpersonal values of healthy subjects who volunteer for phase I clinical trials. Pharmaceutical Medicine, 23(5-6), 299 - 303.

Marques-Lopes, J., Pinto, M., Pinho, D., Morato, M., et al. (2009). Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia. Neuroscience, 158(4), 1301 - 1310.

Almeida, L., Coelho, R., Albino-Teixeira, A., & Soares-Da-Silva, P. (2008). Adverse non-drug-related complaints by healthy volunteers in Phase I studies compared to the healthy general population. International Journal of Clinical Pharmacology and Therapeutics, 46(11), 574 - 583.

Almeida, L., Kashdan, T. B., Coelho, R., Albino-Teixeira, A., & Soares-Da-Silva, P. (2008). Healthy subjects volunteering for phase I studies: Influence of curiosity, exploratory tendencies and perceived self-efficacy. International Journal of Clinical Pharmacology and Therapeutics, 46(3), 109 - 118.

Almeida, L., Falcão, A., Vaz-Da-Silva, M., Coelho, R., et al. (2008). Personality characteristics of volunteers in phase 1 studies and likelihood of reporting adverse events. International Journal of Clinical Pharmacology and Therapeutics, 46(7), 340 - 348.

Morato, M., Sousa, T., & Albino-Teixeira, A. (2008). Purinergic receptors in the splanchnic circulation. Purinergic Signalling, 4(3), 267 - 285.

Sousa, T., Pinho, D., Morato, M., Marques-Lopes, J., et al. (2008). Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. European Journal of Pharmacology, 588(2-3), 267 - 276.

Almeida, L., Kashdan, T. B., Nunes, T., Coelho, R., et al. (2008). Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. European Journal of Clinical Pharmacology, 64(6), 575 - 582.

Morato, M., Pinho, D., Sousa, T., Tavares, I., & Albino-Teixeira, A. (2006). Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla. Journal of Neuroscience Research, 83(4), 647 - 655.

Pinho, D., Sousa, T., Morato, M., Tavares, I., & Albino-Teixeira, A. (2006). Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats. Brain Research, 1073-1074(1), 374 - 382.

Morato, M., Pinho, D., Sousa, T., Guimarães, S., et al. (2006). Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade. European Journal of Pharmacology, 531(1-3), 209 - 216.

Sousa, T., Fernandes, E., Nunes, C., Laranjinha, J., et al. (2005). Scavenging of nitric oxide by an antagonist of adenosine receptors. Journal of Pharmacy and Pharmacology, 57(3), 399 - 404.

Guimarães, S., Carneiro, C., Brandão, F., Pinheiro, H., et al. (2004). A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta. Naunyn-Schmiedeberg's Archives of Pharmacology, 370(4), 262 - 269.

Sousa, T., Morato, M., Fernandes, E., Carvalho, F., & Albino-Teixeira, A. (2004). Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenyl-xanthine (DPSPX), an antagonist of adenosine receptors. Journal of Enzyme Inhibition and Medicinal Chemistry, 19(1), 11 - 15.